|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Y, Shen J, Feng S, Liang R, Lai J, Li
D, Peng B, Wang Z, Huang C and Kuang M: Hepatic resection versus
transarterial chemoembolization in infiltrative hepatocellular
carcinoma: A multicenter study. J Gastroenterol Hepatol.
35:2220–2228. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim JJ, McFarlane T, Tully S and Wong WWL:
Lenvatinib versus sorafenib as first-line treatment of unresectable
hepatocellular carcinoma: A cost-utility analysis. Oncologist.
25:e512–e519. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li J, Zhou M, Liu F, Xiong C, Wang W, Cao
Q, Wen X, Robertson JD, Ji X, Wang YA, et al: Hepatocellular
carcinoma: Intra-arterial delivery of doxorubicin-loaded hollow
gold nanospheres for photothermal ablation-chemoembolization
therapy in rats. Radiology. 281:427–435. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li X, Ramadori P, Pfister D, Seehawer M,
Zender L and Heikenwalder M: The immunological and metabolic
landscape in primary and metastatic liver cancer. Nat Rev Cancer.
21:541–557. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dai S, Mo Y, Wang Y, Xiang B, Liao Q, Zhou
M, Li X, Li Y, Xiong W, Li G, et al: Chronic stress promotes cancer
development. Front Oncol. 10:14922020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Antoni MH and Dhabhar FS: The impact of
psychosocial stress and stress management on immune responses in
patients with cancer. Cancer. 125:1417–1431. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krizanova O, Babula P and Pacak K: Stress,
catecholaminergic system and cancer. Stress. 19:419–428. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xia Y, Wei Y, Li ZY, Cai XY, Zhang LL,
Dong XR, Zhang S, Zhang RG, Meng R, Zhu F and Wu G: Catecholamines
contribute to the neovascularization of lung cancer via
tumor-associated macrophages. Brain Behav Immun. 81:111–121. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Seiler A, Sood AK, Jenewein J and Fagundes
CP: Can stress promote the pathophysiology of brain metastases? A
critical review of biobehavioral mechanisms. Brain Behav Immun.
87:860–880. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bastos DB, Sarafim-Silva BAM, Sundefeld M,
Ribeiro AA, Brandao JDP, Biasoli ER, Miyahara GI, Casarini DE and
Bernabe DG: Circulating catecholamines are associated with
biobehavioral factors and anxiety symptoms in head and neck cancer
patients. PLoS One. 13:e02025152018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang X, Zhang Y, He Z, Yin K, Li B, Zhang
L and Xu Z: Chronic stress promotes gastric cancer progression and
metastasis: An essential role for ADRB2. Cell Death Dis.
10:7882019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang B, Wu C, Chen W, Qiu L, Li S, Wang
T, Xie H, Li Y, Li C and Li L: The stress hormone norepinephrine
promotes tumor progression through beta2-adrenoreceptors in oral
cancer. Arch Oral Biol. 113:1047122020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li XQ, Peng WT, Shan S, Wu JJ, Li N, Du
JJ, Sun JC, Chen TT, Wei W and Sun WY: beta-arrestin2 regulating
beta2-adrenergic receptor signaling in hepatic stellate cells
contributes to hepatocellular carcinoma progression. J Cancer.
12:7287–7299. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cole SW and Sood AK: Molecular pathways:
Beta-adrenergic signaling in cancer. Clin Cancer Res. 18:1201–1206.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nilsson MB, Le X and Heymach JV:
β-adrenergic signaling in lung cancer: A potential role for
beta-blockers. J Neuroimmune Pharmacol. 15:27–36. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Zanos P, Jackson IL, Zhang X, Zhu
X, Gould T and Vujaskovic Z: Psychological stress enhances tumor
growth and diminishes radiation response in preclinical model of
lung cancer. Radiother Oncol. 146:126–135. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou J, Liu Z, Zhang L, Hu X, Wang Z, Ni
H, Wang Y and Qin J: Activation of beta2-adrenergic receptor
promotes growth and angiogenesis in breast cancer by
down-regulating PPARγ. Cancer Res Treat. 52:830–847. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moraes RM, Elefteriou F and Anbinder AL:
Response of the periodontal tissues to β-adrenergic stimulation.
Life Sci. 281:1197762021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qian W, Lv S, Li J, Chen K, Jiang Z, Cheng
L, Zhou C, Yan B, Cao J, Ma Q and Duan W: Norepinephrine enhances
cell viability and invasion, and inhibits apoptosis of pancreatic
cancer cells in a Notch-1-dependent manner. Oncol Rep.
40:3015–3023. 2018.PubMed/NCBI
|
|
21
|
Du P, Zeng H, Xiao Y, Zhao Y, Zheng B,
Deng Y, Liu J, Huang B, Zhang X, Yang K, et al: Chronic stress
promotes EMT-mediated metastasis through activation of STAT3
signaling pathway by miR-337-3p in breast cancer. Cell Death Dis.
11:7612020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu C, Yang Y, Chen C, Li L, Li J, Wang X,
Chu Q, Qiu L, Ba Q, Li X and Wang H: Environmental eustress
modulates beta-ARs/CCL2 axis to induce anti-tumor immunity and
sensitize immunotherapy against liver cancer in mice. Nat Commun.
12:57252021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu J, Qu L, Wan C, Xiao M, Ni W, Jiang F,
Fan Y, Lu C and Ni R: A novel β2-AR/YB-1/β-catenin axis mediates
chronic stress-associated metastasis in hepatocellular carcinoma.
Oncogenesis. 9:842020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Braicu C, Buse M, Busuioc C, Drula R,
Gulei D, Raduly L, Rusu A, Irimie A, Atanasov AG, Slaby O, et al: A
comprehensive review on MAPK: A promising therapeutic target in
cancer. Cancers (Basel). 11:16182019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han J, Jiang Q, Ma R, Zhang H, Tong D,
Tang K, Wang X, Ni L, Miao J, Duan B, et al:
Norepinephrine-CREB1-miR-373 axis promotes progression of colon
cancer. Mol Oncol. 14:1059–1073. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan C, Wu J, Zheng S, Sun H, Fang Y, Huang
Z, Shi M, Liang L, Bin J, Liao Y, et al: Depression accelerates
gastric cancer invasion and metastasis by inducing a neuroendocrine
phenotype via the catecholamine/β2 -AR/MACC1 axis. Cancer Commun
(Lond). 41:1049–1070. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sakakitani S, Podyma-Inoue KA, Takayama R,
Takahashi K, Ishigami-Yuasa M, Kagechika H, Harada H and Watabe T:
Activation of beta2-adrenergic receptor signals suppresses
mesenchymal phenotypes of oral squamous cell carcinoma cells.
Cancer Sci. 112:155–167. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang X, Wang Y, Xie F, Song ZT, Zhang ZQ,
Zhao Y, Wang SD, Hu H, Zhang YS and Qian LJ: Norepinephrine
promotes glioma cell migration through up-regulating the expression
of Twist1. BMC Cancer. 22:2132022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mravec B, Horvathova L and Hunakova L:
Neurobiology of cancer: The role of beta-adrenergic receptor
signaling in various tumor environments. Int J Mol Sci.
21:79582020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bamodu OA, Chang HL, Ong JR, Lee WH, Yeh
CT and Tsai JT: Elevated PDK1 expression drives PI3K/AKT/MTOR
signaling promotes radiation-resistant and dedifferentiated
phenotype of hepatocellular carcinoma. Cells. 9:7462020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Villanueva A: Hepatocellular carcinoma. N
Engl J Med. 380:1450–1462. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pu J, Zhang X, Luo H, Xu L, Lu X and Lu J:
Adrenaline promotes epithelial-to-mesenchymal transition via
HuR-TGFbeta regulatory axis in pancreatic cancer cells and the
implication in cancer prognosis. Biochem Biophys Res Commun.
493:1273–1279. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiao MB, Jin DD, Jiao YJ, Ni WK, Liu JX,
Qu LS, Lu CH, Ni RZ, Jiang F and Chen WC: β2-AR regulates the
expression of AKR1B1 in human pancreatic cancer cells and promotes
their proliferation via the ERK1/2 pathway. Mol Biol Rep.
45:1863–1871. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Decker AM, Jung Y, Cackowski FC, Yumoto K,
Wang J and Taichman RS: Sympathetic signaling reactivates quiescent
disseminated prostate cancer cells in the bone marrow. Mol Cancer
Res. 15:1644–1655. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He JJ, Zhang WH, Liu SL, Chen YF, Liao CX,
Shen QQ and Hu P: Activation of β-adrenergic receptor promotes
cellular proliferation in human glioblastoma. Oncol Lett.
14:3846–3852. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Deng J, Jiang P, Yang T, Huang M, Xie J,
Luo C, Qi W, Zhou T, Yang Z, Zou Y, et al: beta2adrenergic receptor
signaling promotes neuroblastoma cell proliferation by activating
autophagy. Oncol Rep. 42:1295–1306. 2019.PubMed/NCBI
|
|
38
|
Gagliardi PA, Puliafito A and Primo L:
PDK1: At the crossroad of cancer signaling pathways. Semin Cancer
Biol. 48:27–35. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shan T, Cui X, Li W, Lin W, Li Y, Chen X
and Wu T: Novel regulatory program for norepinephrine-induced
epithelial-mesenchymal transition in gastric adenocarcinoma cell
lines. Cancer Sci. 105:847–856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bhat AA, Syed N, Therachiyil L, Nisar S,
Hashem S, Macha MA, Yadav SK, Krishnankutty R, Muralitharan S,
Al-Naemi H, et al: Claudin-1, a double-edged sword in cancer. Int J
Mol Sci. 21:5692020. View Article : Google Scholar : PubMed/NCBI
|
